Introduction
x
OneTouch® Verio™ test strips are used with the built-in One-
Touch® Verio™ meter for the quantitative measurement of blood
glucose in fresh whole capillary blood from the finger, upper arm
and palm. OneTouch® Verio™ Control Solutions are used to verify
that the meter and test strips are working together properly and
that the test is performed correctly.
Contraindications
Insulin pump therapy is NOT recommended for people who are
either:
•
Unable to perform at least four (4)
blood glucose
tests per day
•
Unable to maintain contact with their
healthcare provider
•
Unable to use the System according to instructions
Do not use the integrated OneTouch® Verio™ Blood Glucose
Monitoring System for:
•
Testing on newborns
•
Testing arterial blood
•
Diagnosing of or screening for diabetes mellitus
The mylife OmniPod System is designed to use
rapid-acting U-100 insulin. The following U-100
rapid-acting insulin analogs have been tested and
found to be safe for use in the Pod: NovoRapid®,
Humalog®, or Apidra®. NovoRapid® is compatible
with the mylife OmniPod System for use up to 72
hours (3 days). Before using different insulins with
the mylife OmniPod System, check the insulin drug
label to make sure it can be used with a pump. Refer
to the insulin labeling and follow your healthcare
provider’s directions for how often to replace the Pod.
Not recommended for individuals with hearing
loss. Always verify ability to hear Pod/PDM alerts
and alarms.
The Pod and PDM may be affected by strong radi-
ation or magnetic fields. Before having an X-ray, MRI,
or CT scan (or any similar test or procedure), remove
your Pod and put it and the PDM outside the treat-
ment area. Check with your healthcare provider for
Pod removal guidelines.
Summary of Contents for mylife OmniPod
Page 147: ...Alerts and Alarms 135 10...
